Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GP-Product is a French medical device company specializing in the design and manufacture of high-precision injection systems for aesthetic medicine and mesotherapy. The company is best known for its flagship product, the U225 injector, which is widely regarded as one of the most sophisticated mesotherapy guns on the market due to its pneumatic power and precision. GP-Product's technology is utilized by practitioners worldwide for various applications, including skin rejuvenation, hair loss treatments, and localized pain management. In 2022, the company was acquired by Laboratoires Vivacy, a major player in the aesthetic medicine sector, to strengthen its portfolio of injection solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GP Product.